Here are six quick facts:
1. The company shares decreased 7.58 percent on a four-week period.
2. The shares overtook the S&P 500 by 0.06 percent in the last week.
3. Company shares fell below the index by 11 percent in the past four weeks.
4. Overall, the company shares gained 33.63 percent from its one year high price.
5. The company increased 1.26 percent on Friday, with a gain of 0.74 points.
6. Once trading commenced, the stock reached $59.79 at its peak, settling at $59.36.
More articles on devices:
North America dominates non-fusion spinal devices market: 5 points
Stryker’s VertaPlex HV 1st PMMA to receive FDA clearance for sacral insufficiency fracture treatments: 5 things to know
SeaSpine launches interbody device: 5 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
